KRAS mutations are commonly identified in human ductal carcinomas, whereas they are rarely reported in acinar carcinomas (Cancer Genome Atlas Research Network and Cancer Genome Atlas Research Network 2017), being the latter the most common subtype in dogs. This evidence concerns the gene KRAS and acinar cell carcinoma.